[Inhibition of labour. Symposium by letter (author's transl)].
D000033:Abortion, Threatened / Q000175:diagnosis / Q000628:therapy*; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000431:Ethanol / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects; D005865:Gestational Age; D006221:Halothane / Q000627:therapeutic use; D006801:Humans; D008431:Maternal-Fetal Exchange; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D010922:Placenta Diseases / Q000188:drug therapy; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000150:complications; D011448:Prostaglandin Antagonists / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D011448:Prostaglandin Antagonists; D000431:Ethanol; D006221:Halothane
Medikamentöse Wehenhemmung. Ein schriftliches Symposion